Physician profile
Shane Patrick Sweeney
NPI 1699161356
$112,458.12
in general payments reported to CMS, 2019-2025
4 companies · $29.19 in 2025
The $29.19 reported for 2025 was less than what a typical Anatomic Pathology & Clinical Pathology provider received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $6,525 · 2023: $37K · 2024: $69K · 2025: $29.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $106K · Food and Beverage: $97.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $105,835.99 |
| Food and Beverage | $97.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Plasma INC. | $105,835.99 | 2023-2024 | |
| Csl Behring | $6,525.00 | 2022 | |
| Hologic Sales and Service, LLC | $75.76 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Abiomed | $21.37 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Sweeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.